Pietro Merli

5.2k total citations
109 papers, 1.8k citations indexed

About

Pietro Merli is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Pietro Merli has authored 109 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Hematology, 41 papers in Immunology and 38 papers in Oncology. Recurrent topics in Pietro Merli's work include Hematopoietic Stem Cell Transplantation (45 papers), Immune Cell Function and Interaction (30 papers) and CAR-T cell therapy research (26 papers). Pietro Merli is often cited by papers focused on Hematopoietic Stem Cell Transplantation (45 papers), Immune Cell Function and Interaction (30 papers) and CAR-T cell therapy research (26 papers). Pietro Merli collaborates with scholars based in Italy, United States and Germany. Pietro Merli's co-authors include Franco Locatelli, Luisa Strocchio, Mattia Algeri, Francesca Moretta, Marco Zecca, Barbarella Lucarelli, Letizia Pomponia Brescia, Francesca Del Bufalo, Alice Bertaina and Patrizia Comoli and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Pietro Merli

100 papers receiving 1.8k citations

Peers

Pietro Merli
Carmem Bonfim Brazil
Ho Joon Im South Korea
Matthias Eyrich Germany
Toshihiko Imamura Japan
Marrie C.A. Bruin Netherlands
Asahito Hama Japan
Tohru Inaba Japan
Andrew Daly Canada
Jun Ooi Japan
Aiko Suminoe Japan
Carmem Bonfim Brazil
Pietro Merli
Citations per year, relative to Pietro Merli Pietro Merli (= 1×) peers Carmem Bonfim

Countries citing papers authored by Pietro Merli

Since Specialization
Citations

This map shows the geographic impact of Pietro Merli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pietro Merli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pietro Merli more than expected).

Fields of papers citing papers by Pietro Merli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pietro Merli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pietro Merli. The network helps show where Pietro Merli may publish in the future.

Co-authorship network of co-authors of Pietro Merli

This figure shows the co-authorship network connecting the top 25 collaborators of Pietro Merli. A scholar is included among the top collaborators of Pietro Merli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pietro Merli. Pietro Merli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rose, Domenico Umberto De, Francesca Campi, Iliana Bersani, et al.. (2025). Off-Label Use of Anakinra in Inflammatory Conditions in Neonates and Infants Up to 3 Months of Age: A Case Series and a Review of the Literature. Pediatric Drugs. 27(3). 293–305.
2.
Marasco, Emiliano, Claudia Bracaglia, Pietro Merli, et al.. (2024). P101 Anti-CD19 CAR-T cell therapy for refractory childhood-onset systemic lupus erythematosus. SHILAP Revista de lepidopterología. A113.1–A113. 6 indexed citations
3.
Bufalo, Francesca Del, Pietro Merli, Daria Pagliara, et al.. (2024). CD7.Pebl-CART for Patients with Relapsed/Refractory (r/r) T-Cell Acute Lymphoblastic Leukemia (T-ALL). Blood. 144(Supplement 1). 4830–4830. 1 indexed citations
4.
Bordoni, Veronica, Federica Galaverna, Valentina Bertaina, et al.. (2024). Antiviral potential of Vδ2 T cells in children given TCR αβ/CD19 cell-depleted HLA-haploidentical HSCT. Blood Advances. 9(5). 990–1002. 1 indexed citations
5.
Pigazzi, Martina, Pietro Merli, Pamela Scarparo, et al.. (2023). Prognostic Role of Molecular MRD Variations during Treatment of Pediatric AML: A Retrospective AIEOP AML2013/01 Study. Blood. 142(Supplement 1). 422–422. 1 indexed citations
6.
Bracaglia, Claudia, Manuela Pardeo, Giulia Marucci, et al.. (2023). AB1429 EMAPALUMAB TREATMENT FOLLOWED BY HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS COMPLICATED BY RECURRENT MACROPHAGE ACTIVATION SYNDROME. Annals of the Rheumatic Diseases. 82. 1943–1944.
7.
Algeri, Mattia, Enrico Velardi, Marco Spada, et al.. (2023). Achievement of operational tolerance in a pediatric liver transplant recipient following successful hematopoietic stem cell transplantation from a different donor. American Journal of Transplantation. 23(9). 1446–1450.
8.
Masetti, Riccardo, Davide Leardini, Edoardo Muratore, et al.. (2023). Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children. Blood. 142(16). 1387–1398. 25 indexed citations
9.
Baldo, Giada Del, Francesca Del Bufalo, Claudia Pinacchio, et al.. (2023). The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumors. Frontiers in Immunology. 14. 18 indexed citations
10.
11.
Vennarini, Sabina, Giada Del Baldo, Stefano Lorentini, et al.. (2022). Acute Hematological Toxicity during Cranio-Spinal Proton Therapy in Pediatric Brain Embryonal Tumors. Cancers. 14(7). 1653–1653. 6 indexed citations
12.
Merli, Pietro, Daria Pagliara, Federica Galaverna, et al.. (2021). TCRαβ/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders. Blood Advances. 6(1). 281–292. 25 indexed citations
13.
Strocchio, Luisa, Daria Pagliara, Mattia Algeri, et al.. (2021). HLA-haploidentical TCRαβ+/CD19+-depleted stem cell transplantation in children and young adults with Fanconi anemia. Blood Advances. 5(5). 1333–1339. 15 indexed citations
14.
Ceglie, Giulia, Laura Papetti, Massimiliano Valeriani, & Pietro Merli. (2020). Hematopoietic Stem Cell Transplantation in Neuromyelitis Optica-Spectrum Disorders (NMO-SD): State-of-the-Art and Future Perspectives. International Journal of Molecular Sciences. 21(15). 5304–5304. 20 indexed citations
15.
Biagi, Elena, Daniele Zama, Simone Rampelli, et al.. (2019). Early gut microbiota signature of aGvHD in children given allogeneic hematopoietic cell transplantation for hematological disorders. BMC Medical Genomics. 12(1). 49–49. 54 indexed citations
16.
17.
Vinti, Luciana, Franco Locatelli, Pietro Merli, et al.. (2017). Brentuximab Vedotin in Combination with Bendamustine in Relapsed or Refractory Hodgkin Lymphoma: A Retrospective Analysis on 23 Paediatric Patients or Young Adults. Blood. 130. 4090–4090. 2 indexed citations
18.
Bertaina, Alice, Alessia Zorzoli, Andrea Petretto, et al.. (2016). Zoledronic acid boosts γδ T-cell activity in children receiving αβ+T and CD19+cell-depleted grafts from an HLA-haplo-identical donor. OncoImmunology. 6(2). e1216291–e1216291. 52 indexed citations
19.
Savasta, Salvatore, Pietro Merli, Luisa Strocchio, et al.. (2012). Agenesis of Internal Carotid Artery and Hypopituitarism: Case Report and Review of Literature. The Journal of Clinical Endocrinology & Metabolism. 97(10). 3414–3420. 7 indexed citations
20.
Magni‐Manzoni, Silvia, Carlo Alberto Scirè, Angelo Ravelli, et al.. (2012). Ultrasound-detected synovial abnormalities are frequent in clinically inactive juvenile idiopathic arthritis, but do not predict a flare of synovitis. Annals of the Rheumatic Diseases. 72(2). 223–228. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carmem Bonfim Breakdown of academic impact, for papers by Ho Joon Im Breakdown of academic impact, for papers by Matthias Eyrich Breakdown of academic impact, for papers by Toshihiko Imamura Breakdown of academic impact, for papers by Marrie C.A. Bruin Breakdown of academic impact, for papers by Asahito Hama Breakdown of academic impact, for papers by Tohru Inaba Breakdown of academic impact, for papers by Andrew Daly Breakdown of academic impact, for papers by Jun Ooi Breakdown of academic impact, for papers by Aiko Suminoe
Rankless by CCL
2026